BNGO - Bionano Genomics Inc. (BNGO) Q4 2023 Earnings Call Transcript
2024-03-05 21:54:02 ET
Bionano Genomics, Inc. (BNGO)
Q4 2023 Earnings Conference Call
March 5, 2024 16:30 ET
Company Participants
David Holmes - Investor Relations
Erik Holmlin - Chief Executive Officer
Gulsen Kama - Chief Financial Officer
Conference Call Participants
Sung Ji Nam - Scotiabank
Mark Massaro - BTIG
Jeff Cohen - Ladenburg Thalmann
Michael Okunewitch - Maxim Group
Presentation
Operator
Good day and welcome to the Bionano Fourth Quarter and Full Year 2023 Earnings Conference Call. Today’s conference is being recorded. At this time, I would like to turn the conference over to David Holmes from Investor Relations. Please go ahead.
David Holmes
Thank you and good afternoon everyone. Welcome to the Bionano fourth quarter and full year 2023 financial results conference call. Leading the call today is Dr. Erik Holmlin, CEO of Bionano. He is joined by Gulsen Kama, CFO of Bionano. After market closed today, Bionano issued a press release announcing its financial results for the fourth quarter and full year 2023. A copy of the release can be found on the Investor Relations page of the company’s website.
I would like to remind everyone that certain statements made during the conference call are forward-looking, including statements about Bionano’s strategic and commercialization plans, sales pipeline, future fundraising activities and prospects, cash runway, expected cost savings initiatives and the estimated impact on annualized operating expenses; the timing of expected benefits and such initiatives, expected reductions in headcount; anticipated benefits or improvements to the Stratys, Saphyr and Ionic Purification System and their advantages over current technologies, goals and anticipated milestones for 2024 and achievements of the Elevate growth strategy; our anticipated compound annual growth rate; the size of our ability to access our estimated target markets; the anticipated benefits of recent acquisitions; expectations regarding the timing and the content study results and the anticipated benefits of these studies driving adoption of the Stratys System, Saphyr System and the Ionic Purification System....
Bionano Genomics, Inc. (BNGO) Q4 2023 Earnings Call Transcript